D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 48 Citations 12,690 85 World Ranking 2330 National Ranking 55

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Malaria

Jorge Alvar mainly investigates Leishmaniasis, Immunology, Visceral leishmaniasis, Virology and Epidemiology. His study of Leishmania infantum is a part of Leishmaniasis. His biological study spans a wide range of topics, including Disease and Intensive care medicine.

His research in Visceral leishmaniasis intersects with topics in Global health, Internal medicine, Incidence and Pharmacology. The Virology study combines topics in areas such as Genotype, Apicomplexa and Polymerase chain reaction. His Epidemiology study frequently draws connections to other fields, such as Acquired immunodeficiency syndrome.

His most cited work include:

  • Leishmaniasis Worldwide and Global Estimates of Its Incidence (3074 citations)
  • Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? (1139 citations)
  • The Relationship between Leishmaniasis and AIDS: the Second 10 Years (630 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Leishmaniasis, Visceral leishmaniasis, Immunology, Virology and Leishmania infantum. His Leishmaniasis study combines topics from a wide range of disciplines, such as Epidemiology, Incidence, Disease and Leishmania. His Visceral leishmaniasis study incorporates themes from Veterinary medicine, Internal medicine, Pharmacotherapy and Intensive care medicine.

His Acquired immunodeficiency syndrome research extends to Immunology, which is thematically connected. His study in the field of Viral disease and Infectivity also crosses realms of Xenodiagnosis. The concepts of his Leishmania infantum study are interwoven with issues in Phlebotomus, Kinetoplastida, Psychodidae and Asymptomatic.

He most often published in these fields:

  • Leishmaniasis (55.19%)
  • Visceral leishmaniasis (49.35%)
  • Immunology (29.87%)

What were the highlights of his more recent work (between 2016-2020)?

  • Visceral leishmaniasis (49.35%)
  • Leishmaniasis (55.19%)
  • Internal medicine (16.88%)

In recent papers he was focusing on the following fields of study:

Jorge Alvar focuses on Visceral leishmaniasis, Leishmaniasis, Internal medicine, Miltefosine and Incidence. The study incorporates disciplines such as Veterinary medicine, Asymptomatic and Intensive care medicine in addition to Visceral leishmaniasis. Leishmaniasis is a subfield of Immunology that he investigates.

His work on Pharmacotherapy, Prospective cohort study, Disease burden and Survival analysis is typically connected to Major depressive disorder as part of general Internal medicine study, connecting several disciplines of science. His research integrates issues of Regimen, Adverse effect and Combination therapy in his study of Miltefosine. His Incidence research incorporates elements of Global health, Epidemiology, Neglected tropical diseases and Cutaneous leishmaniasis.

Between 2016 and 2020, his most popular works were:

  • Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme. (58 citations)
  • Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives. (53 citations)
  • Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies. (46 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Pathology

Visceral leishmaniasis, Leishmaniasis, Internal medicine, Miltefosine and Paromomycin are his primary areas of study. His study in Visceral leishmaniasis is interdisciplinary in nature, drawing from both Leishmania, Pharmacotherapy and Asymptomatic. His Leishmaniasis study results in a more complete grasp of Immunology.

His Internal medicine study combines topics in areas such as Global health and Cutaneous leishmaniasis. His Miltefosine research integrates issues from Regimen and Intensive care medicine. As part of one scientific family, Jorge Alvar deals mainly with the area of Post-kala-azar dermal leishmaniasis, narrowing it down to issues related to the Phlebotomus, and often Parasite load, Dermatology and Incidence.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Leishmaniasis Worldwide and Global Estimates of Its Incidence

Jorge Alvar;Iván D. Vélez;Iván D. Vélez;Caryn Bern;Mercé Herrero.
PLOS ONE (2012)

4632 Citations

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

François Chappuis;François Chappuis;Shyam Sundar;Asrat Hailu;Hashim Ghalib.
Nature Reviews Microbiology (2007)

1757 Citations

The Relationship between Leishmaniasis and AIDS: the Second 10 Years

Jorge Alvar;Pilar Aparicio;Abraham Aseffa;Margriet Den Boer.
Clinical Microbiology Reviews (2008)

994 Citations

Leishmania and human immunodeficiency virus coinfection: the first 10 years.

J Alvar;C Cañavate;B Gutiérrez-Solar;M Jiménez.
Clinical Microbiology Reviews (1997)

984 Citations

Leishmaniasis and poverty.

Jorge Alvar;Sergio Yactayo;Caryn Bern.
Trends in Parasitology (2006)

826 Citations

Canine leishmaniasis: epidemiological risk and the experimental model

Javier Moreno;Jorge Alvar.
Trends in Parasitology (2002)

551 Citations

Leishmania/HIV co-infections: epidemiology in Europe.

P. Desjeux;J. Alvar.
Annals of Tropical Medicine and Parasitology (2003)

496 Citations

Complexities of assessing the disease burden attributable to leishmaniasis.

Caryn Bern;James H. Maguire;Jorge Alvar.
PLOS Neglected Tropical Diseases (2008)

417 Citations

Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus

R. Molina;C. Amela;J. Nieto;M. San-Andrés.
Transactions of The Royal Society of Tropical Medicine and Hygiene (1994)

401 Citations

Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis

Caryn Bern;Jill Adler-Moore;Juan Berenguer;Marleen Boelaert.
Clinical Infectious Diseases (2006)

342 Citations

Best Scientists Citing Jorge Alvar

Shyam Sundar

Shyam Sundar

Banaras Hindu University

Publications: 159

Jean-Claude Dujardin

Jean-Claude Dujardin

Institute of Tropical Medicine Antwerp

Publications: 115

Marleen Boelaert

Marleen Boelaert

Institute of Tropical Medicine Antwerp

Publications: 101

Mehdi Mohebali

Mehdi Mohebali

Tehran University of Medical Sciences

Publications: 99

Filipe Dantas-Torres

Filipe Dantas-Torres

Oswaldo Cruz Foundation

Publications: 63

Petr Volf

Petr Volf

Charles University

Publications: 58

Francine Pratlong

Francine Pratlong

University of Montpellier

Publications: 58

Simon L. Croft

Simon L. Croft

University of London

Publications: 56

Luigi Gradoni

Luigi Gradoni

Istituto Superiore di Sanità

Publications: 55

Domenico Otranto

Domenico Otranto

University of Bari Aldo Moro

Publications: 47

Gabriele Schönian

Gabriele Schönian

Charité - University Medicine Berlin

Publications: 44

Peter J. Hotez

Peter J. Hotez

Baylor College of Medicine

Publications: 43

Alon Warburg

Alon Warburg

Hebrew University of Jerusalem

Publications: 41

Alexandre Barbosa Reis

Alexandre Barbosa Reis

Universidade Federal de Ouro Preto

Publications: 41

Manuel Soto

Manuel Soto

Autonomous University of Madrid

Publications: 39

Paul M. Kaye

Paul M. Kaye

Hull York Medical School

Publications: 36

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.